title: Abdominal Wall Grafts: A Viable Addition to Arteriovenous Access Strategies.
abstract: BACKGROUND
  We seek to present our experience with innovative abdominal wall arteriovenous access grafts for patients who have run out of traditional dialysis access options.
  
  
  METHODS
  We retrospectively reviewed our cohort of patients who have undergone creation of abdominal wall grafts. In all patients, an iliac artery was used for inflow and either an iliac vein or the distal inferior vena cava (IVC) was use for the outflow. Ringed polytetrafluorethylene (PTFE), nonringed PTFE, and bovine carotid artery were used as access conduits.
  
  
  RESULTS
  Our 12-patient cohort had a mean primary patency of 17.4 months with mean secondary patency of 33 months. There were no operative deaths noted and 4 total graft infections.
  
  
  CONCLUSIONS
  Abdominal wall grafts with iliac vessel inflow and/or outflow represent viable alternatives for patients who have exhausted more traditional dialysis access options.
authors.affiliation: Division of Vascular and Endovascular Surgery, USF Health Morsani College of Medicine, Tampa, FL. Electronic address: mwooster@health.usf.edu.
authors.forename: Mathew
authors.initials: M
authors.lastname: Wooster
authors.affiliation: Division of Vascular and Endovascular Surgery, USF Health Morsani College of Medicine, Tampa, FL.
authors.forename: Alexis
authors.initials: A
authors.lastname: Powell
authors.affiliation: College of Arts and Sciences, Florida State University, Tallahassee, FL.
authors.forename: Jay
authors.initials: J
authors.lastname: Denisco
authors.affiliation: Division of Surgery, Tampa General Medical Group, Tampa, FL.
authors.forename: Victor
authors.initials: V
authors.lastname: Bowers
mesh_terms: D034861:Abdominal Wall / Q000601:surgery*; D000328:Adult; D000368:Aged; D000818:Animals; D001166:Arteriovenous Shunt, Surgical / Q000379:methods*; D001807:Blood Vessel Prosthesis; D002417:Cattle; D005260:Female; D006801:Humans; D007083:Iliac Artery; D007084:Iliac Vein; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011138:Polytetrafluoroethylene; D006435:Renal Dialysis; D012189:Retrospective Studies; D058017:Vascular Grafting; D014654:Vascular Patency; D014682:Vena Cava, Inferior
chemical_list: D011138:Polytetrafluoroethylene